SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is a major talking point following a significant price retracement that has sharply divided the crypto community. Many express bearish views, labeling it a "scam" or "worthless" and suggesting a flight to gold and silver, with some attributing the drop to institutional selling and leveraged long liquidations. In contrast, staunch bulls are framing the current dip as a "bear trap" and a compelling "buy opportunity," maintaining confidence in a future rebound.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention following its expanded pipeline, including the acquisition of VLX-1005, and ongoing collaboration with Abbott for the pivotal Phase 3 trial of tecarfarin in anticoagulation. The community is actively discussing the substantial market opportunity for its novel therapies and the potential for volatility due to its ultra-low float, alongside prevalent skepticism regarding funding and perceived promotional bot activity.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending due to reports of a substantial U.S. government investment, including a 10% equity stake and debt financing, aimed at bolstering domestic critical mineral supply chains. The community is highly bullish, anticipating significant price appreciation and potential short squeezes, drawing comparisons to past government-backed plays in the rare earth sector. This strategic backing underscores the company's crucial role in national security and the broader push to secure essential materials for high-tech industries.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

The biotech sector, represented by LABU, is experiencing robust upward momentum, largely driven by market optimism surrounding potential Federal Reserve rate cuts and the transformative impact of AI on drug discovery. This rally is further amplified by ongoing significant buyout activities within the sector, sparking widespread community discussion about a substantial recovery and capital rotation into biotech, despite some expressing caution regarding its rapid ascent.

Sumitomo Mitsui Financial Group, Inc. operates as a holding company, which engages in the management of its subsidiaries that provide financial services. It operates through the following segments: Wholesale, Retail, Global, Market and Head Office Management. The Wholesale Business segment dealings with domestic large corporations and small and medium-sized enterprises. The Retail Business segment dealings with domestic individual customers. The Global Business segment dealings with overseas Japanese and non-Japanese companies. The Market Business segment operations related to financial markets. The Head Office Management segment that does not belong to any of the above business divisions. The company was founded on December 2, 2002 and is headquartered in Tokyo, Japan.

Sumitomo Mitsui Financial Group Inc - ADR

Sumitomo Mitsui Financial Group Inc (Ads)

Sumitomo Mitsui Financial Group is trending amid robust financial results, including record profits and strong earnings forecasts, along with shareholder return initiatives like share buybacks and enhanced dividends. The community is also closely watching the Bank of Japan's evolving monetary policy, anticipating further interest rate increases expected to significantly benefit Japanese mega-banks. Additionally, prominent investor interest in the Japanese financial sector, notably from Warren Buffett, continues to draw attention to the group's long-term stability and value.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending as the biotech sector experiences a relentless uptrend, fueled by factors like ongoing buyouts and speculative interest in AI integration. This persistent rise in the underlying XBI index is causing immense frustration among many LABD holders, who are debating market manipulation and desperately seeking signs of an imminent, yet elusive, reversal. The community is actively discussing the sustainability of this 'parabolic' rally and when the overextended biotech sector might finally experience a significant pullback.

Spring Valley Acquisition Corp. III is a blank check company. It was created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on March 12, 2025 an is headquartered in Dallas, TX.

Spring Valley Acquisition Corp III - Ordinary Shares - Class A

SVAC is generating significant buzz following its definitive business combination agreement with General Fusion, positioning it to become the first publicly traded pure-play nuclear fusion company. The community is highly optimistic about this long-term energy play, drawing comparisons to successful SPACs like SMR and OKLO, notably highlighting Jeff Bezos's backing and the Spring Valley team's prior success. Investors are actively discussing the groundbreaking potential of nuclear fusion technology and the perceived early entry opportunity into this transformative sector.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as investors debate the actual impact of a widespread cold snap across the U.S. on natural gas prices. Many believe the natural gas rally is overextended, with the severe weather effects already priced in, citing minimal confirmed production shut-offs and falling LNG exports. Conversely, others fear the full extent of power outages and potential freeze-offs could continue to drive natural gas higher, creating significant volatility for this inverse ETF.

Dogelon Mars

Dogelon Mars is trending amidst significant community discussion following a major exchange delisting and growing frustration over unfulfilled promises like a 'Great Burn' and 'Metaverse' by the end of Q2. While many investors are labeling it a long-term 'scam' or 'dead coin' due to its lagging performance, a dedicated subset continues to 'buy the dip,' clinging to hope for a future catalyst from its namesake or a surprise development.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending on intense speculation surrounding a potential acquisition by a major pharmaceutical player like Merck, with community conversations centered on the significant value of its RAS(ON) inhibitor pipeline, especially its promising pancreatic cancer treatments. While prior buyout rumors created volatility, market participants are now weighing the company's strong scientific foundation against the persistent M&A chatter, fueled by recent analyst upgrades. The biotech sector's drive for innovative cancer therapies provides a compelling backdrop to RVMD's continued momentum.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
